BlossomHill Therapeutics (BLSM) News
NASDAQ: BLSMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
17.48+0.60 (+3.55%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
BLSM news summary
We found 2 recent headlines mentioning BlossomHill Therapeutics (BLSM): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, BLSM is up 3.55% at $17.48. The most recent story, "Biotech Stocks At 52-Week Highs - BLSM +18% On Positive Trial Data, ADPT, ILMN, CBLL, NEOG", was published by Nasdaq on Sep 17, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology
Latest BlossomHill Therapeutics headlines
- Biotech Stocks At 52-Week Highs - BLSM +18% On Positive Trial Data, ADPT, ILMN, CBLL, NEOG(RTTNews) - The following biotech stocks reached a 52-week high on September 16, 2026, driven by positive results from clinical trials or an upcoming conference participation.NasdaqADPT, BLSM, CBLL, ILMN
- Biotech Stocks At 52-Week Highs - NEO, BLSM, RVMD, ORMP, CADL(RTTNews) - The following biotech stocks reached a 52-week high on August 27, 2026, driven by key catalysts like various regulatory milestones.NasdaqBLSM, CADL, NEO, ORMP